MRNA: Moderna Inc Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 29,808.78
Enterprise Value ($M) 26,876.78
Book Value ($M) 13,455.00
Book Value / Share 35.29
Price / Book 2.22
NCAV ($M) 4,804.00
NCAV / Share 12.60
Price / NCAV 6.20

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 2.35
Current Ratio 2.46

Balance Sheet (mrq) ($M)
Current Assets 10,799.00
Assets 19,450.00
Liabilities 5,995.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-10 13G/A Bancel Stephane 7.41 -7.57
02-09 13G/A Vanguard Group Inc 7.10 -0.53
02-01 13G/A BlackRock Inc. 6.80 -5.59
01-19 13G/A Baillie Gifford & Co 11.66 -2.15

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-04 10-Q Form 10-Q
2023-02-24 10-K Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-11-29 466,015 2,079,886 22.41
2023-11-28 396,851 1,800,751 22.04
2023-11-27 521,058 2,527,026 20.62
2023-11-24 443,246 2,152,974 20.59

(click for more detail)

Similar Companies
MNPR – Monopar Therapeutics Inc MORF – Morphic Holding Inc
MRKR – Marker Therapeutics Inc MRNS – Marinus Pharmaceuticals Inc
MRSN – Mersana Therapeutics Inc


Financial data and stock pages provided by
Fintel.io